XNCR Stock — Xencor Inc

Up next

Next earnings call

Dec 30, 2026 Est · unconfirmed · in 22 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 6, 2026

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 18.2 · elevated Equity put/call 0.71

Technical

price trend

Strong Buy

50 / 200-day cross Golden cross

Price vs 200-day avg +46%

above

Price vs 50-day avg +42%

above

RSI (14) 74

overbought

MACD trend Positive

52-week position 91%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +33%

trailing

6-month return +65%

trailing

YTD return +30%

this year

Relative strength +57%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) Golden cross

50d $14 › 200d $14 — 50d above 200d

Institutional flow Distributing

36 of 202 funds reported for Jun 30 · net -44.6K sh shares · +5 new

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

14.62% of float · ▼ -5.8% MoM · 13.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

202 holders — mid 3-yr range

Squeeze score 76

high risk · 0–100

Fundamentals

Fair

Revenue growth +14%

Y/Y

EPS growth +65%

Y/Y

Free cash flow $-138.3M

Balance sheet $65.7M

net debt

Quant / Vol

risk profile

Very High

Volatility 66%

annualized · 1-yr

Max drawdown −43%

past year

ATR 6.2%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed May 6, 2026

Cash, cash equivalents and marketable debt securities · end of 2026 Initiated $380M – $400M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Buy

1 · 1 · 5

50 / 200-day cross

Golden cross Bullish

Price vs 200-day avg

+46% Bullish

Price vs 50-day avg

+42% Bullish

RSI (14)

74 Bearish

MACD trend

Positive Bullish

52-week position

91% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) Golden cross

50d $14 › 200d $14 — 50d above 200d

Institutional flow Distributing

36 of 202 funds reported for Jun 30 · net -44.6K sh shares · +5 new

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

14.62% of float · ▼ -5.8% MoM · 13.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

202 holders — mid 3-yr range

Price context

position in its 52-week range

52-wk low $7 Now $20 · 91% 52-wk high $21

vs 200-day avg +46% vs 50-day avg +42% 50-day above 200-day golden cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
XNCR Xencor Inc this stock	$1.47B	+30.4%	+13.7%	—	14.6%
ONC BeOne Medicines Ltd.	$471.01B	+7.3%	+22179.2%	958.5	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$121.57B	+8.2%	+46.2%	28.4	2.0%
REGN Regeneron Pharmaceuticals, Inc.	$69.95B	-9.8%	+20.8%	16.3	3.3%
ARGX Argenx SE	$55.61B	+3.7%	—	—	2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

203

% held: 109.1%
Reported: 36 of 202
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

234

View

Short & Settlement

Short Interest Falling

Shares short

10.8M

Days to cover: 13.6d
Change: -664.2K sh

View

Short Volume

Short vol %

68%

As of: Jul 28, 2026

Short Total

View

Fails to Deliver

FTD shares

268

Value: $4.0K
As of: Jun 26, 2026

View

Off-Exchange

Off-exchange %

35.0%

Week of: May 4, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$125.6M

Net income (FY): $-91.9M
EPS diluted: $-1.24

View

Filings

SEC Filings

Latest

8-K

Filed: Jun 18, 2026
This year: 11

View

Proposed Sales

Value

$89.4K

Shares: 6.8K
Filed: Jun 18, 2026

View

Exempt Offerings

Offering

$25.0M

Filed: Nov 19, 2021

View

Earnings & Events

Earnings Calls

Last call

May 6, 2026

View

	5D	20D	120D	MTD	YTD
XNCR	+6.2%	+32.7%	+64.9%	+24.0%	+30.4%
SPY	-1.0%	0.0%	+7.4%	-0.8%	+8.6%
vs SPY	+7.2%	+32.7%	+57.5%	+24.8%	+21.8%

XNCR · Xencor Inc

Price & Indicators

Up next

Equibles Rating

Guidance & track record

Technicals

Versus peers

At a glance

Performance